EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial

Jean‐Christophe Rozé, Gilles Cambonie, Cyril Flamant, Juliana Patkaï, Tobias Muehlbacher, Géraldine Gascoin-Lachambre, Aline Rideau Batista Novais, Manon Tauzin, Kévin Le Duc, Alain Beuchée, Sébastien Joye, Evgeniya Babacheva und 19 weitere

Zurich Open Repository and Archive (University of Zurich) · 16.02.2026

DOI: 10.5167/uzh-433963 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Zurich Open Repository and Archive (University of Zurich), erschienen am 16.02.2026. Verfasst von Jean‐Christophe Rozé und 30 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance: Controversies persist about management of the ductus arteriosus by nonsteroidal anti-inflammatory drugs in extremely preterm infants. Acetaminophen (paracetamol) appears to be a promising alternative with possibly fewer adverse effects.

Objective

To evaluate whether prophylactic intravenous acetaminophen started within 12 hours of birth increases survival without neonatal severe morbidities at 36 weeks' postmenstrual age. Design, setting, and participants: A double-blind, randomized, placebo-controlled clinical trial was conducted among preterm infants born between 23 weeks 0 days and 28 weeks 6 days of gestation in 43 neonatal intensive care units of 14 European countries between October 2020 (October 2021 for infants born at 23-26 weeks' gestation, after the phase 2 study identified the optimal dose of acetaminophen) and April 2024. Data analysis was conducted from January to June 2025.

Intervention

In the acetaminophen group, patients born at 27 to 28 weeks' gestation received a 20-mg/kg loading dose of acetaminophen followed by 7.5 mg/kg every 6 hours for 5 days, and patients born at 23 to 26 weeks' gestation received a 25-mg/kg loading dose of acetaminophen followed by 10 mg/kg every 6 hours for 5 days. In the placebo group, isotonic sodium chloride was administered. Main outcomes and measures: The primary outcome was survival without neonatal morbidity evaluated at 36 weeks' postmenstrual age. The secondary exploratory outcome was ductus arteriosus closure, assessed by echocardiography on day 7.

Results

A total of 778 patients (median [IQR] gestational age, 26 [25-27] weeks; 375 [48.2%] female) were included in the study, with 391 in the acetaminophen group and 387 in the placebo group. Survival without severe morbidities at 36 weeks' postmenstrual age occurred in 259 infants (66.2%) in the acetaminophen group and 246 (63.6%) in the placebo group (absolute risk difference [ARD], 2.7 [95% CI, -4.0 to 9.3] percentage points; relative risk [RR], 1.04 [95% CI, 0.94 to 1.16]). The ductus arteriosus was considered closed on day 7 in 264 of 371 infants (71.2%) assigned to acetaminophen and 191 of 366 infants (52.2%) assigned to placebo (ARD, 19.0 [95% CI, 12.0 to 25.7] percentage points; RR, 1.36 [95% CI, 1.21 to 1.53]). In the safety analysis, adverse events were not different except for a higher cholestasis rate in the acetaminophen group (25 of 392 infants [6.4%]) vs the placebo group (10 of 386 infants [2.6%]) (ARD, 3.8 [95% CI, 0.9 to 6.9]) percentage points. Conclusions and relevance: This study found that prophylactic acetaminophen treatment for patent ductus arteriosus did not increase survival without neonatal morbidities.

Trial registration

ClinicalTrials.gov Identifier: NCT04459117.

Schlagwörter

patent ductus arteriosusparacetamolextremely preterm infantsductus arteriosus closureneonatal survivalneonatal morbiditypharmacological prophylaxisnonsteroidal anti-inflammatory drugsneonatal intensive careneonatal sepsis

Zitieren

APA

Rozé, J., Cambonie, G., Flamant, C., Patkaï, J., Muehlbacher, T., Gascoin-Lachambre, G., Novais, A. R. B., Tauzin, M., Duc, K. L., Beuchée, A., Joye, S., Babacheva, E., Bouissou, A., Ligi, I., Tammela, O. K., Plourde, M., Dempsey, E., Tosello, B., Nguyen, K. A., …, & al, E. (2026). Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial. Zurich Open Repository and Archive (University of Zurich). https://doi.org/10.5167/uzh-433963

Vancouver

Rozé J, Cambonie G, Flamant C, Patkaï J, Muehlbacher T, Gascoin-Lachambre G, et al. Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial. Zurich Open Repository and Archive (University of Zurich). 2026. doi:10.5167/uzh-433963

BibTeX
@article{Roz2026,
  author = {Rozé, Jean‐Christophe and Cambonie, Gilles and Flamant, Cyril and Patkaï, Juliana and Muehlbacher, Tobias and Gascoin-Lachambre, Géraldine and Novais, Aline Rideau Batista and Tauzin, Manon and Duc, Kévin Le and Beuchée, Alain and Joye, Sébastien and Babacheva, Evgeniya and Bouissou, Antoine and Ligi, Isabelle and Tammela, Outi K.T. and Plourde, Marion and Dempsey, Eugene and Tosello, Barthélémy and Nguyen, Kim An and Vincent, Marine and Andresson, Pille and Binder, Christoph and Kruse, Charlotte Duhn and Munoz, Francisca Barcos and Kuhn, Pierre and Proença, Elisa and Bartocci, Marco and Kermorvant‐Duchemin, Elsa and Nellis, Georgi and Lumia, Mirka and al, et},
  title = {Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen: A Randomized Clinical Trial},
  journal = {Zurich Open Repository and Archive (University of Zurich)},
  year = {2026},
  doi = {10.5167/uzh-433963}
}
Kostenlos starten →